Summary
Is a different approach to pricing agreements between pharma and payers the path to introduction of new, innovative medicine? What problem do we solve with outcome-based risk sharing agreements and what is the perspective for patients, the public sector, and the pharma industry respectively?
Outcome-based risk sharing agreements are not a new phenomenon. Yet innovative pricing is still quite rare, among other because of a high level of complexity and limited experiences.
Get the required knowledge to assess if innovative pricing is the path towards market introduction for your product. When does it make sense?
Gain insight into the various types of outcome-based risk sharing agreements, learn about the experiences that already exist and get to know where to find data and how you can set up an outcome-based risk sharing agreement.
The course builds on the Danish market, but we also cover the rest of Scandinavia and discuss risk sharing agreements in a national and global perspective.
Hi!
Do you need help choosing the right course?
We are ready to help you at +45 39 27 60 60 or contact@atriumcph.com
Keywords
- Outcome-based pricing agreement
- RSA (risk sharing agreements)
- Innovative pricing
- RWD/real world data
- Market Access
- Medical affairs
Save information for later
Course leader & lecturers
- Tove Holm-LarsenCourse leaderCEO
Pharmaevidence
Watch the video
Is this course for you?
This course is relevant for you if you work in Market Access, Commercial or Medical Affairs or in Clinical project development.
What you will learn
- Understand the thinking behind outcome-based risk sharing agreements
- Understand how to put a price on risk in various constellations of public-private collaboration
- Get an overview of where to find data for outcome-based risk sharing agreements
- Understand the concern of the public system and the pharma industry respectively
What your company will get
- An employee who understands the national and global perspectives in outcome-based risk sharing agreements
- An employee who knows about the different types of outcome-based risk sharing agreements
- An employee who knows where to find data for the outcome-based risk sharing agreements
- An employee who knows about the management of risk sharing agreements in Scandinavia
Course calendar
Day 1
- Light breakfast and networking
- Outcome-based risk sharing agreements - which problem are we trying to solve?
- Outcome-based risk sharing agreements - which problem are we trying to solve, as seen from the patient?
- Outcome-based risk sharing agreements - which problem are we trying to solve, as seen from the public perspective?
- Lunch and networking
- Helicopter view: Presentation of the Danish system
- Different types of outcome-based risk sharing agreements
- Nordic overview: How do they work with outcome-based risk sharing agreements in the other Scandinavian countries?
Day 2
- Light breakfast and networking
- Panel discussion: What is Pharma’s perspective on outcome-based risk sharing agreements on a national and global level?
- Presentation of a real case implementation in Denmark
- Lunch and networking
- Presentation of model simulations from the Danish OSCAR project
- Where can you find relevant data and how do you get access to them?
- Wrap up and evaluation
Registration
Registration deadline29 Nov 2023
Lersø Parkallé 101
2100 København Ø
Course information
Literature
Life Science Insights’ report, executive summary. Download the report here.
Prerequisites
Min. 3 years’ experience in Market Access, Medical Affairs or Commercial within Pharma.
Examination
There is no examination for this course.
The course is part of the Market Access diploma programme
This course is a part of a diploma
Our Diploma in Market Access provides you with in-depth knowledge of the Danish healthcare system and its funding models and stakeholders. Raise your skill level in areas such as public affairs, stakeholder management and health economics by attending the four courses
Read moreCourse leader
Pharmaevidence
You may also be interested in these courses
Want to know more or need help?
Contact Contact Client Manager Ida Salicath at +45 39 15 09 46
Send me a message